| Disease associated variation - GWASdb |
| Chr | Pos | SNP ID(dbSNP 142) | Ref | Alt | Ori SNP ID | P-value | Drug Name | Drug Anno | GWAS Trait | HPO ID | DO ID | AA | Type | Trait or Drug |
|---|
| 5 | 37671746 | rs12521063 | T | C | rs12521063 | 1.00E-04 | TOPIRAMATE|FRUCTOSE | ANTICONVULSANTS | Cognitive impairment induced by topiramate | HPOID:0100543 | DOID:1561 | T | intron | GWASdb_drug |
| 5 | 37696178 | rs6451339 | T | C | rs6451339 | 1.00E-04 | TOPIRAMATE|FRUCTOSE | ANTICONVULSANTS | Cognitive impairment induced by topiramate | HPOID:0100543 | DOID:1561 | T | intron | GWASdb_drug |
| 5 | 37409579 | rs13178300 | C | T | rs13178300 | 2.20E-04 | | | Vaspin levels | HPOID:0001513|HPOID:0000855|HPOID:0005978 | DOID:9970|DOID:9352 | C | intron | GWASdb_trait |
| 5 | 37409579 | rs13178300 | C | T | rs13178300 | 0.0002196 | | | Treatment outcomes for selective serotonin reuptake inhibitors (SSRIs) - remission at 8 weeks | HPOID:0000716 | DOID:1470 | C | intron | GWASdb_trait |
| 5 | 37424855 | rs2056871 | C | T | rs2056871 | 7.00E-06 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | G | intron | GWASdb_trait |
| 5 | 37492210 | rs7715951 | T | A | rs7715951 | 8.00E-07 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | A | intron | GWASdb_trait |
| 5 | 37506332 | rs11957546 | T | C | rs11957546 | 8.00E-07 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | C | intron | GWASdb_trait |
| 5 | 37556926 | rs2088077 | A | G | rs2088077 | 0.000609 | | | Schizophrenia | HPOID:0100753 | DOID:5419 | A | intron | GWASdb_trait |
| 5 | 37585849 | rs665327 | G | A | rs665327 | 5.00E-06 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | A | intron | GWASdb_trait |
| 5 | 37586211 | rs677084 | G | A | rs677084 | 5.00E-06 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | A | intron | GWASdb_trait |
| 5 | 37587570 | rs10941345 | A | C | rs10941345 | 5.88E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | A | intron | GWASdb_trait |
| 5 | 37648563 | rs12656733 | G | T | rs12656733 | 5.00E-06 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | G | intron | GWASdb_trait |
| 5 | 37671746 | rs12521063 | T | C | rs12521063 | 1.00E-04 | | | Cognitive impairment induced by topiramate | HPOID:0100543 | DOID:1561 | T | intron | GWASdb_trait |
| 5 | 37696178 | rs6451339 | T | C | rs6451339 | 1.30E-06 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | T | intron | GWASdb_trait |
| 5 | 37696178 | rs6451339 | T | C | rs6451339 | 1.00E-04 | | | Cognitive impairment induced by topiramate | HPOID:0100543 | DOID:1561 | T | intron | GWASdb_trait |
| 5 | 37700516 | rs4869544 | C | T | rs4869544 | 4.74E-10 | | | Biliary atresia | HPOID:0005912 | DOID:13608 | T | intron | GWASdb_trait |
| 5 | 37716067 | rs4242252 | A | G | rs4242252 | 9.55E-05 | | | Weight | HPOID:0004323 | DOID:9970 | G | intron | GWASdb_trait |
| 5 | 37731359 | rs1019505 | T | A | rs1019505 | 5.00E-06 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | T | intron | GWASdb_trait |
| 5 | 37743077 | rs6451341 | G | C | rs6451341 | 4.20E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | C | intron | GWASdb_trait |